New Woodlands storefront brings hologram technology to the car-shopping experience

vr-oom

The Woodlands Mall shoppers can schedule virtual test drives, complete purchases, schedule deliveries of vehicles and meet with staff at this new high-tech store. Photo courtesy of JLL

The Woodlands-based online pre-owned car purveyor evrdrive has opened its flagship Customer Experience Center, or CXC, at The Woodlands Mall.

Designed by JLL Design Solutions, the modern space will allow shoppers to virtually tour the company's fleet of vehicles through its evrViewTM 3D hologram technology. According to a release, the technology can show evrdrive's full inventory of SUVs, cars, trucks, or other body styles and can display the vehicle's model specifications and history.

From the storefront, shoppers can also schedule virtual test drives, complete purchases, schedule deliveries of vehicles and meet with staff.

"We believe evrdrive is the future of automotive retail, and we are committed to providing our customers with a seamless and enjoyable shopping experience," Brian Singh, CEO of evrdrive, said in a statement.

evrdrive was founded in 2022, according to LinkedIn, and is part of Foundation Automotive Corp, a Houston-based company that owns car dealerships in the U.S. and Canada.

The company also runs a 55,000-square-foot Reconditioning Hub in the Houston area where vehicles are inspected and refurbished.

A number of new innovative auto ventures have rolled into Houston in recent months.

Self-driving ridehailing service Cruise expanded into Houston with its all electric, driverless cars in early May. The company launched services in Austin at the start of the year.

Uber Technologies, Inc. and Nuro also partnered last September to provide autonomous, electric vehicles for food deliveries in Houston. That same month, Drvn, a global on-demand chauffeur service, began operating in the Bayou City.

Drvn offers tech-savvy service, high-end cars, and various ride options. Photo courtesy of drvn

New tech-enabled chauffeur service stretches into Houston with upscale ride options

stay classy

Discriminating Houstonians who opt for luxury/executive car services (and who don’t, unfortunately, have a limo and driver of their own) now can choose an innovative, tech-savvy option.

Drvn, a global chauffeur service, has just rolled into Houston. Customers can look forward to on-demand rides — 24 hours a day — in various, upscale vehicles. Options start with first class; cars offered include sedans (Mercedes S Class, BMW 7 Series, or similar); SUVs (Cadillac Escalade, Lincoln Navigator, or similar); and even vans (such as the Mercedes 1500).

Business class also offers sedans (Cadillac XTS, Lincoln Continental, or similar); SUVs (Chevrolet Suburban, Ford Expedition, or similar); and also vans (Ford Transit or similar).

Private charters for posh parties or travel parties include Grech minibuses (or similar) that can seat up to 36 passengers. Limousines are available upon request and subject to availability. All vehicles are black, for a more classic touch.

Just in time for society/gala season, drvn offers locals rides to events all around Greater Houston, as well as both major airports. (Drvn’s CEO David Medina tells CultureMap that the service is a hit in its Coral Gables, Florida headquarters, where well-heeled customers use it for event travel.)

Other service areas include port transfers to and from the Port of Galveston; drvn’s long-distance car service to Dallas; Oklahoma City; Shreveport, Louisiana; Baton Rouge, Louisiana; Little Rock, Arkansas; and beyond. Drvn staff expects major demand for events, conventions, and conferences, plus executive car service for business clients.

Currently, those interested can book rides via the drvn site. Medina notes that a customer app is scheduled for later this year.

As for the cost: A simple search from the Memorial Park area to Bush Intercontinental Airport yielded point-to-point rides starting at around $226 in an executive class sedan. Users can also schedule and even request special cars and opt for hourly service (perfect for weddings, occasions, and that visiting celebrity friend).

Aiming to separate itself from local high-end car services, drvn promises “five-star, white-glove transportation” options, cutting-edge booking technology, and drivers who meticulously train and even undergo secret rides from drvn staff to assure quality control. Drvn hopes to entice business/executive car service clients with tech such as God’s view and GPS tracking (to keep tabs on the boss’s car), a live manifest, and uniform billing and communication.

Medina also hopes to separate his company by redefining what luxury actually means when it comes to car service.

“‘Luxury’ does not mean luxury for high-end private car service,” he says. “Luxury is a Flying Spur or a Bentayga, not a Mercedes S Class or an Escalade. But, a Bentley is not what is in the mind of professionals who seek ‘luxury’ private car service. It is a state of being. It is knowing, without saying, that your chauffeur not only has your best interests in mind, he has your experience in mind. It is part of his duty of care to know what you expect and deliver it with elegance and with no visible exertion. It is through the simplicity of this balance that drvn’s chauffeured service delivers a ‘luxury’ experience. Not the Bentley.”

------

This article originally ran on CultureMap.

NuVinAir ReKlenz-X is safe for use in vehicles and can be used without damaging the interior. Photo courtesy of NuVinAir

New product sold in Houston gets EPA approval as eco-friendly, coronavirus-killing car cleaner

IN-CAR TECH

With the onset of COVID-19, the public is more aware than ever of cross-contamination, which extends from your home to your business to your car, and beyond.

NuVinAir announced that its latest product, ReKlenz-X, has gotten approval from the Environmental Protection Agency (EPA) as an eco-friendly disinfectant. The company's Houston affiliate, Brian Ross, is selling the product.

ReKlenz-X kills 99.9 percent of germs, bacteria, and viruses in a vehicle's interior without compromising the integrity of the cabin. The product is on the EPA's "List N", which includes disinfectants for use to combat SARS-CoV-2, the virus that causes COVID-19."NuVinAir has proudly been at the forefront of helping ensure healthier commutes to drivers and passengers since launching in 2015. Adding this EPA-approved, oxygen-infused product that actually kills what's behind the coronavirus gives us an exciting extension to our 'Total Health' application," says Kyle Bailey, NuVinAir Global's CEO and founder.

"Our science-backed ReKlenz-X disinfectant cleans, protects, and disinfects safely and effectively — it's everything our automotive partners need in guaranteeing their customers' confidence in a safer, healthier vehicle," he continues.

To clean, the proprietary product uses an oxygen-enriched formula to quickly kills bacteria and viruses by destroying their cell walls through a process called oxidation. According to NuVinAir, ReKlenz-X contains no harsh chemicals, sticky residue, or dangerous volatile organic compounds. The result is a disinfected vehicle with no chemical smell.

ReKlenz-X is available in 32-ounce spray bottles through automotive dealerships, detail shops, rental-car companies, service centers, and vehicle fleets.

"Until now, any possible solution for killing the coronavirus was wrought with harmful chemicals, expensive equipment, and residue-leaving application devices that destroy the vehicle's interior," said Troy Blackwell, Chief Operating Officer for NuVinAir Global. "As a disinfectant and sanitizer, it can be applied to all interior vehicle surfaces using a microfiber towel. Paired with our premier detailing solution, ReNuSurface, as well as our patented Cyclone treatment, it takes deep cleaning to a whole new level for our automotive partners and their customers."

Dallas, Texas-based NuVinAir sells their products through a franchise system, similar to Line-X's business model.

------

This article originally ran on AutomotiveMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston robotics co. closes series B after year of growth

money moves

Houston- and Boston-based Square Robot Inc. closed a series B round of funding last month.

The advanced submersible robotics company raised $13 million, according to Tracxn.com, and says it will put the funds toward international expansion.

"This Series B round, our largest to date, enables us to accelerate our growth plans and meet the surging global demand for our services,” David Lamont, CEO, said in a statement.

The company aims to establish a permanent presence in Europe and the Middle East and grow its delivery services to reach four more countries and one new continent in Q1 2025.

Additionally, Square Robot plans to release a new robot early next year. The robot is expected to be able to operate in extreme temperatures up to 60 C. The company will also introduce its first AI-enabled tools to improve data collection.

Square Robot launched its Houston office in 2019. Its autonomous, submersible robots are used for storage tank inspections and eliminate the need for humans to enter dangerous and toxic environments.

The company was one of the first group of finalists for the Houston Innovation Awards' Scaleup of the Year, which honors a Bayou City company that's seen impressive growth in 2024. Click here to read more about the company's growth.

------

This article originally ran on EnergyCapital.

Show me the money: Top Houston innovation grant and gift news of 2024

year in review

Editor's note: As the year comes to a close, InnovationMap is looking back at the year's top stories in Houston innovation. Money means a lot to startups and other innovative entities, and while startups are usually scouting venture capital investors, grants and donations are key too. These are the most-read news articles about grants and gifts — be sure to click through to read the full story.

Rice researchers secure $35M federal grant to advance medical device technology

Rice’s Biotech Launch Pad will lead the effort to commercialize the device. Photo courtesy Rice University

Rice University has secured part of a nearly $35 million federal grant aimed at commercializing a bioelectric implant for treatment of type 2 diabetes and obesity.

The federal Advanced Research Projects Agency for Health awarded the $34.9 million grant to Rice and several other universities.

Rice’s Biotech Launch Pad will lead the effort to commercialize the self-contained, implantable Rx On-site Generation Using Electronics (ROGUE) device. ROGUE houses cells that are engineered to produce type 2 diabetes and obesity therapies in response to patients’ needs. Continue reading.

Houston health care institutions receive $22M to attract top recruits

The grants, which are between $2 million to $6 million each, are earmarked for recruitment of prominent researchers. Photo via Getty Images

Houston’s Baylor College of Medicine has received a total of $12 million in grants from the Cancer Prevention & Research Institute of Texas to attract two prominent researchers.

The two grants, which are $6 million each, are earmarked for recruitment of Thomas Milner and Radek Skoda. The Cancer Prevention & Research Institute of Texas (CPRIT) announced the grants May 14.

Milner, an expert in photomedicine for surgery and diagnostics, is a professor of surgery and biomedical engineering at the Beckman Laser Institute & Medical Clinic at the University of California, Irvine and the university’s Chao Family Comprehensive Cancer Center. Continue reading.

New report ranks Houston top market for life sciences

Houston lands in the No. 7 spot for growth in the granting of degrees in biological and biomedical sciences. Photo by Natalie Harms/InnovationMap

Thanks in large part to producing hundreds of college-trained professionals, Houston’s life sciences industry ranks among the top U.S. markets for talent in 2024.

In a report published by commercial real estate services company CBRE, Houston lands in the No. 7 spot for growth in the granting of degrees in biological and biomedical sciences. From 2017 to 2022, Houston notched a growth rate of 32.4 percent in this category.

In 2022, the University of Houston led the higher education pack in the region, graduating 746 people with a bachelor’s degree or above in biological or biomedical sciences, according to the report. Continue reading.

Texas organization grants $68.5M to Houston institutions for recruitment, research

Several Houston organizations have received millions from the Cancer Prevention and Research Institute of Texas. Photo via tmc.edu

Three prominent institutions in Houston will be able to snag a trio of high-profile cancer researchers thanks to $12 million in new funding from the Cancer Prevention and Research Institute of Texas.

The biggest recruitment award — $6 million — went to the University of Texas MD Anderson Center to lure researcher Xiling Shen away from the Terasaki Institute for Biomedical Innovation in Los Angeles.

Shen is chief scientific officer at the nonprofit Terasaki Institute. His lab there studies precision medicine, including treatments for cancer, from a “systems biology perspective.” Continue reading.

Houston health care institution secures $100M for expansion, shares renderings

Baylor College of Medicine's Lillie and Roy Cullen Tower is set to open in 2026. Rendering courtesy of SLAM Architecture

Baylor College of Medicine has collected $100 million toward its $150 million fundraising goal for the college’s planned Lillie and Roy Cullen Tower.

The $100 million in gifts include:

  • A total of $30 million from The Cullen Foundation, The Cullen Trust for Health Care, and The Cullen Trust for Higher Education.
  • $12 million from the DeBakey Medical Foundation
  • $10 million from the Huffington Foundation
  • More than $45 million from members of Baylor’s Board of Trustees and other community donors, including the M.D. Anderson Foundation, the Albert and Margaret Alkek Foundation, and The Elkins Foundation.

“The Cullen Trust for Health Care is very honored to support this building along with The Cullen Foundation and The Cullen Trust for Higher Education,” Cullen Geiselman Muse, chair of The Cullen Trust for Health Care, says in a news release. “We cannot wait to see what new beginnings will come from inside the Lillie and Roy Cullen Tower.” Continue reading.

TMC launches cancer-focused partnership with Japan

global collaboration

Houston's Texas Medical Center announced the launch of its new TMC Japan BioBridge and Japan-Accelerator Cancer Therapeutics and Medical Devices, or JACT, this month.

The strategic partnership between Japan-based Mitsui Fudosan Co. Ltd. and the National Cancer Center will focus on advancing cancer treatments and providing a pathway for Japanese innovators to expand in the U.S. market. A delegation from TMC recently visited Tokyo, and William F. McKeon, president and CEO of TMC, signed the TMC Japan BioBridge Memorandum of Understanding with Takeshi Ozane, general manager of Mitsui Fudosan, and Hitoshi Nakagama, president of the National Cancer Center of Japan.

“The launch of TMC Japan BioBridge is a vital step forward in connecting two global leaders in healthcare innovation,” McKeon says in a statement. “Japan’s leadership has demonstrated an impressive commitment to advance medical cures and life sciences technologies and through this partnership, we are opening necessary doors for Japanese researchers and innovators to access the US market and collaborate with our TMC ecosystem. Together, we aim to accelerate critical breakthroughs to make a difference for patients all around the world.”

The new JACT will offer cancer-treatment companies a structured process to prepare for a U.S. expansion and will allow for meetings with pharmaceutical companies, hospital systems and investors and provide insights on U.S. regulatory approvals. It'll focus on three key areas, according to the statement:

  1. Milestone development and financial planning
  2. Clinical and regulatory expertise
  3. Strategic partnerships and market insights

“This TMC Japan BioBridge and JACT Program will enable us to promote the advancement of start-up companies aiming to commercialize innovative medical technologies originating in Japan into the U.S." Nakagama says in a statement. "We also hope this collaboration will not be limited to our (Japan Agency for Medical Research and Development)-supported project, but will lead to further cooperation between TMC, NCC, and other Japanese institutions in various fields.”

This is the sixth international strategic partnership for the TMC. It launched its first BioBridge, which focus on partnerships to support international healthcare companies preparing for U.S. expansion, with the Health Informatics Society of Australia in 2016. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.

View All Listings